HCRTR2 rs11046206: What Your Genotype Means
The rs11046206 variant is a single nucleotide polymorphism located within the HCRTR2 gene, which encodes a receptor critical for regulating sleep and wakefulness. Research suggests this variant may be associated with variations in daytime sleepiness and sleep architecture, though the evidence remains limited.
What each genotype means
Typical daytime alertness pattern
You carry two copies of the common A allele for this HCRTR2 marker. Research on hypocretin receptor variation suggests this genotype represents baseline receptor signaling, with no established association with increased daytime sleepiness or fragmented sleep architecture. However, evidence remains limited, and lifestyle habits play a far larger role in overall sleep quality.
Carried by approximately 80% to 85% of individuals of European ancestry and is the predominant genotype across global populations.
Mildly altered sleep architecture tendency
You carry one copy of the less common G allele at rs11046206. Preliminary association studies link hypocretin receptor 2 variations to subtle shifts in sleep-wake stability, such as daytime sleepiness or altered sleep continuity, but evidence is limited and non-diagnostic. These findings reflect modest population correlations rather than a definitive sleep disorder.
Carried by roughly 15% to 20% of people of European ancestry; frequencies vary among other ancestral groups.
Atypical orexin signaling tendency
You carry two copies of the minor G allele for this HCRTR2 variant. While research indicates the hypocretin/orexin system is essential for maintaining sustained wakefulness, evidence linking this specific homozygous genotype to altered daytime sleepiness and sleep architecture remains limited and exploratory. This genotype does not diagnose narcolepsy or any clinical hypersomnia.
Carried by approximately 1% of individuals in European populations, making it uncommon.
Understanding the rs11046206 Variant
The rs11046206 variant is a specific genetic change, or single nucleotide polymorphism (SNP), found within the HCRTR2 gene. Located on chromosome 6, this gene provides instructions for creating the hypocretin receptor 2 protein. In genomics, a SNP represents a variation at a single position in the DNA sequence among individuals. While many SNPs have no observable effect on health or traits, others are studied for their potential to influence biological processes. The rs11046206 variant is categorized as a trait-associated marker, meaning researchers have investigated whether the presence of specific alleles at this location correlates with differences in human sleep patterns. Because this variant sits within a gene known to be central to arousal and sleep regulation, it has become a subject of interest for scientists studying the genetic underpinnings of sleep architecture.
The Role of the HCRTR2 Gene
The HCRTR2 gene encodes the orexin 2 receptor, a G protein-coupled receptor that plays a fundamental role in the central nervous system. This receptor is activated by neuropeptides called orexins (also known as hypocretins), which are produced in the hypothalamus. When orexins bind to the HCRTR2 receptor, they trigger signaling pathways that modulate neuronal excitability and help maintain wakefulness. This system is essential for stabilizing the sleep-wake cycle and regulating energy metabolism. Disruptions in the orexin system are well-documented in severe sleep disorders, such as narcolepsy, where the loss of orexin-producing neurons leads to excessive daytime sleepiness and sudden muscle weakness. Because of its central role in keeping the brain alert, variations in the HCRTR2 gene are frequently investigated to see if they contribute to more subtle differences in how individuals experience sleep, alertness, and circadian rhythms.
Research and Evidence Strength
Current scientific evidence linking rs11046206 to specific sleep traits is considered limited. While the HCRTR2 gene is undeniably important for sleep regulation, the specific impact of the rs11046206 variant is not fully established. Some studies have explored associations between HCRTR2 polymorphisms and traits like daytime sleepiness or sleep architecture, but these findings often require larger, more diverse cohorts to confirm. It is important to distinguish between rare, highly penetrant mutations that cause clinical sleep disorders and common variants like rs11046206, which may only exert minor influences on sleep behavior. Because sleep is a complex trait influenced by many genes and environmental factors, a single SNP is unlikely to be the sole determinant of an individual's sleep quality. Consequently, any observed associations should be viewed as preliminary, and the variant is not currently used as a diagnostic tool for sleep disorders.
Interpreting Your Genetic Information
If you have access to your genetic data regarding rs11046206, it is important to understand what this information can and cannot tell you. This variant is a tool for scientific research into population-level trends, not a medical test for diagnosing sleep conditions. You cannot use this information to predict your personal sleep health or to make decisions about medical treatments. If you are experiencing persistent sleep disturbances, such as excessive daytime sleepiness, insomnia, or difficulty waking, you should consult a healthcare professional or a sleep specialist. They can provide a clinical evaluation that considers your full medical history, lifestyle, and other relevant factors. Never use genetic data to self-diagnose or alter any prescribed medication regimens. Always discuss any concerns about your sleep or potential medication side effects with your doctor or a licensed pharmacist.
How common is this variant?
The minor allele for rs11046206 has a frequency of approximately 0.10 in European ancestries, though frequencies can vary across different global populations.
Frequently asked questions
Is rs11046206 a cause of narcolepsy?
No. While the HCRTR2 gene is involved in the biology of narcolepsy, the rs11046206 variant is a common polymorphism and is not considered a diagnostic marker or a primary cause of clinical narcolepsy.
Can I use this SNP to predict my sleep quality?
No. Sleep quality is a complex trait influenced by many genetic and environmental factors. This SNP does not provide enough information to predict your personal sleep patterns or quality.
Should I change my medication based on this genotype?
Absolutely not. You should never change or stop any medication based on genetic information. Always consult your physician or pharmacist before making any changes to your treatment plan.
Where can I find more information on HCRTR2?
You can find reliable information on the HCRTR2 gene through resources like the NCBI Gene database, MedlinePlus Genetics, and the GWAS Catalog.
Sources & further reading
Educational information only, last refreshed 10/19/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs11046206?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in HCRTR2
While historically investigated for cluster headache susceptibility, recent large-scale meta-analyses and genetic association studies have yielded inconsistent or non-significant results regarding its clinical impact.
Non-synonymous variant (Val308Ile) in hypocretin/orexin receptor type 2 implicated in daytime somnolence and altered sleep architecture.
Hypocretin/orexin receptor 2 regulatory variant linked to excessive daytime sleepiness and disrupted REM sleep stabilization.